Healthcare Executive David Bingaman to Join Millennium Healthcare, Inc. as New President

MELVILLE, NY--(Marketwired - Jul 30, 2015) - Millennium Healthcare, Inc. (OTCQB: MHCC), a developer and distributor of healthcare services and medical devices, today announced the appointment of industry executive David Bingaman as President and member of the Board of Directors effective August 15, 2015.

Prior to joining Millennium, Mr. Bingaman was a senior member of the founding executive team, Regional President/CEO and Senior VP of National Operations of American Medical Response (AMR). As a seasoned healthcare executive that brings over 25 years of experience in healthcare, he developed and oversaw the operations of 250 operating centers in 44 states, generating annual revenues of $1.3 billion.

Mr. Bingaman implemented national business process improvements by incorporating a wide-array of productivity processes, operations/financial key performance indicator metrics, competitive pricing standards, value propositions and contract templates, resulting in consistently reduced operational costs while increasing bottom-line profitability by increasing top line growth and improved performance up to 33% during his tenure. In addition, AMR was awarded 12 national "best in class" service operations awards.

Mr. Bingaman was a key executive of the AMR Team that completed and integrated more than 70 acquisitions during his tenure. He exceeded publicly traded budget targets for 20 quarters; which resulted in substantial growth and grew shareholder value from $8.50 per share at merger IPO to $40.00 per share at exit through this national rollout in just under 5 years.

David Bingaman, Millennium's incoming President said, "I am very excited to join the Millennium team and have high confidence in the opportunities and our positioning in the market place, moving forward."

Noel Mijares, Millennium's CEO, stated, "We are excited to welcome David as our new President. His acquisition oriented experience coupled with his operational expertise will be a tremendous asset to our executive management team. We are very confident that David's abilities and experience will generate tangible benefits to our valued shareholders."

Mijares continued, "We are beyond grateful to our current President, Chris Amandola, for his leadership in growing Millennium to date and look forward to his continued relationship with the Company. Though he will be exiting the post of President, Chris will remain an important leader of the company in other capacities to help us ensure Millennium's future success."

About Millennium Healthcare Inc. (www.millenniumhcs.net)
Millennium Healthcare Inc., through its wholly owned operating subsidiaries, provides hospitals, primary care physician practices, physician groups and healthcare facilities of all sizes with cutting-edge technology driven applications, systems and medical devices focused primarily on preventive care through early detection. The Company also provides advanced billing and coding services, and practice development and management services. For more information, please visit www.millenniumhcs.net.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This press release contains certain statements that may constitute "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Forward-looking statements are identified by such words and phrases as "we expect," "expected to," "estimates," "estimated," "current outlook," "we look forward to," "would equate to," "projects," "projections," "projected to be," "anticipates," "anticipated," "we believe," "could be," and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. Because they are forward-looking, they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.